358 research outputs found
Mientras los hombres trabajan las mujeres planchan : análisis discursivo del manual de texto para niños y niñas Windows 6
"En este ejercicio investigativo se busca identificar las representaciones sociales generizadas que se encuentran en un manual de texto de inglés como lengua extranjera para la educación secundaria. Adicionalmente, esta investigación se concentrará de igual manera en la relación existente entre la instrucción pedagógica y su relación con la aparición de actores (mujeres y hombres) para delimitar si efectivamente se presenta alguna incidencia entre la instrucción de las actividades y el empleo de imágenes. Para llevar a cabo este estudio, se propone una combinación de elementos del Análisis Crítico del Discurso (ACD) (van Dijk, 2004) y las teorizaciones de Kress y van Leeuwen (2006) desde una perspectiva visual como herramienta esencial que pudiese ayudar a establecer la relación del manual de texto con respecto a la representación del género. Vale la pena destacar que el corpus elegido para esta investigación es un libro de texto perteneciente a una de las editoriales más conocidas de Colombia. Este trabajo concluye que a través de los contenidos pedagógicos, culturales y ""críticos"" es posible perpetuar un estereotipo generizado en el pensamiento de los estudiantes como parecen indicarlo las representaciones sociales de género identificadas. El trabajo discute las implicaciones pedagógicas e investigativas de este hallazgo aduciendo la necesidad de transitar de las representaciones hacia las prácticas sociales alrededor de los libros de texto utilizados para la enseñanza del inglés como lengua extranjera."Licenciado (a) en Lenguas ModernasPregrad
Influence of Loading Conditions on the Mechanical Performance of Multifilament Coreless UHMWPE Sutures Used in Orthopaedic Surgery
This work studies the influence of loading velocity and previous cyclic loading history
on the stiffness and strength of a multifilament coreless ultra-high-molecular-weight polyethylene
(UHMWPE) surgical suture. Thread samples (n = 8) were subjected to a load-to-failure test at 0.1, 0.5,
1, 5, and 10 mm/s without previous loading history and after 10 cycles of loading at 1–10 N, 1–30 N,
and 1–50 N. The experimental data were fitted to mathematical models to compute the stress–strain
relation and the strength of the suture. The bilinear model involving two stress–strain ratios for lowand high-strain intervals was the best fit. The ratio in the low-strain range rose with loading speed,
showing mean increases of 5.9%, 6.5%, 7.9%, and 7.3% between successive loading speeds. Without a
previous loading history, this ratio was less than half than that at high strain. However, 10 cycles of
1–30 N or 1–50 N significantly increased the stress–strain ratio at a low strain level by 135% and 228%,
respectively. The effect persisted after 2 min but vanished after 24 h. No influence was found on the
suture strength. In conclusion, the stiffness of the studied suture was influenced by the strain level,
loading velocity, and recent cyclic loading history. Conversely, the suture strength was not affected.This research was funded by the Ministerio de Ciencia, Innovación y Universidades de España, grant number RTI2018-094339-B-100, and the Consejería de Economia, Conocimiento, Empresas y Universidades de Andalucia, Spain, grant number P20-00294. Partial funding for open access charge: Universidad de Málag
Integrating invasive species policies across ornamental horticulture supply-chains to prevent plant invasions
1.Ornamental horticulture is the primary pathway for invasive alien plant introductions. We critically appraise published evidence on the effectiveness of four policy instruments that tackle invasions along the horticulture supply chain: pre-border import restrictions, post-border bans, industry codes of conduct and consumer education. 2.Effective pre-border interventions rely on rigorous risk assessment and high industry compliance. Post-border sales bans become progressively less effective when alien species become widespread in a region. 3.A lack of independent performance evaluation and of public disclosure, limits the uptake and effectiveness of voluntary codes of conduct and discourages shifts in consumer preference away from invasive alien species. 4.Policy implications. Closing the plant invasion pathway associated with ornamental horticulture requires government-industry agreements to fund effective pre- and post-border weed risk assessments that can be subsequently supported by widely adopted, as well as verifiable, industry codes of conduct. This will ensure producers and consumers make informed choices in the face of better targeted public education addressing plant invasions
Intensification of Antiretroviral Therapy with a CCR5 Antagonist in Patients with Chronic HIV-1 Infection: Effect on T Cells Latently Infected
Objective: The primary objective was to assess the effect of MVC intensification on latently infected CD4+ T cells in
chronically HIV-1-infected patients receiving antiretroviral therapy.
Methods: We performed an open-label pilot phase II clinical trial involving chronically HIV-1-infected patients receiving
stable antiretroviral therapy whose regimen was intensified with 48 weeks of maraviroc therapy. We analyzed the latent
reservoir, the residual viremia and episomal 2LTR DNA to examine the relationship between these measures and the HIV-1
latent reservoir, immune activation, lymphocyte subsets (including effector and central memory T cells), and markers
associated with bacterial translocation.
Results: Overall a non significant reduction in the size of the latent reservoir was found (p = 0.068). A mean reduction of 1.82
IUPM was observed in 4 patients with detectable latent reservoir at baseline after 48 weeks of intensification. No effect on
plasma residual viremia was observed. Unexpectedly, all the patients had detectable 2LTR DNA circles at week 24, while
none of them showed those circles at the end of the study. No changes were detected in CD4+ or CD8+ counts, although a
significant decrease was found in the proportion of HLA-DR+/CD38+ CD4+ and CD8+ T-cells. LPS and sCD14 levels increased.
Conclusions: Intensification with MVC was associated with a trend to a decrease in the size of the latent HIV-1 reservoir in
memory T cells. No impact on residual viremia was detected. Additional studies with larger samples are needed to confirm
the results
AG5 is a potent non-steroidal anti-inflammatory and immune regulator that preserves innate immunity
12 pages, 5 figures.-- This is an open access article under the CC BY-NC-ND licenseAn archetypal anti-inflammatory compound against cytokine storm would inhibit it without suppressing the innate immune response. AG5, an anti-inflammatory compound, has been developed as synthetic derivative of andrographolide, which is highly absorbable and presents low toxicity. We found that the mechanism of action of AG5 is through the inhibition of caspase-1. Interestingly, we show with in vitro generated human monocyte derived dendritic cells that AG5 preserves innate immune response. AG5 minimizes inflammatory response in a mouse model of lipopolysaccharide (LPS)-induced lung injury and exhibits in vivo anti-inflammatory efficacy in the SARS-CoV-2-infected mouse model. AG5 opens up a new class of anti-inflammatories, since contrary to NSAIDs, AG5 is able to inhibit the cytokine storm, like dexamethasone, but, unlike corticosteroids, preserves adequately the innate immunity. This is critical at the early stages of any naïve infection, but particularly in SARS-CoV-2 infections. Furthermore, AG5 showed interesting antiviral activity against SARS-CoV-2 in humanized miceThis work has been supported by NextGenerationEU Recovery and Resilience Facility (RRF) through the PTI+ Global Health Platform of Spanish National Research Council, grants SGL2103023 (PBA), SGL2103053 (MMA) and SGL2103015 (MM); by Spanish National Research Council through the program “Ayudas extraodinarias a proyectos de investigacion en el marco de las medidas urgentes extraodinarias para hacer frente al impacto económico y social del COVID-19”, grants CSIC-COV19-093 (PBA) and CSIC-COV19-117 (MM); by Generalitat Valenciana through the program “Ayudas urgentes para proyectos de investigación, desarrollo tecnológico e innovación (I+D+i) por la COVID-19”, grant GVA-COVID19/2021/059 (PBA); by the Conference of Rectors of the Spanish Universities, Spanish National Research Council and Banco Santander through the FONDO SUPERA COVID-19, grant CAPriCORn (JSM, JMB); by Severo Ochoa center of excellence program (grant CEX2021-001230-S) (PBA)Peer reviewe
Resetting translational homeostasis restores myelination in Charcot-Marie-Tooth disease type 1B mice
Clonal chromosomal mosaicism and loss of chromosome Y in elderly men increase vulnerability for SARS-CoV-2
The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID-19) had an estimated overall case fatality ratio of 1.38% (pre-vaccination), being 53% higher in males and increasing exponentially with age. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, we found 133 cases (1.42%) with detectable clonal mosaicism for chromosome alterations (mCA) and 226 males (5.08%) with acquired loss of chromosome Y (LOY). Individuals with clonal mosaic events (mCA and/or LOY) showed a 54% increase in the risk of COVID-19 lethality. LOY is associated with transcriptomic biomarkers of immune dysfunction, pro-coagulation activity and cardiovascular risk. Interferon-induced genes involved in the initial immune response to SARS-CoV-2 are also down-regulated in LOY. Thus, mCA and LOY underlie at least part of the sex-biased severity and mortality of COVID-19 in aging patients. Given its potential therapeutic and prognostic relevance, evaluation of clonal mosaicism should be implemented as biomarker of COVID-19 severity in elderly people. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, individuals with clonal mosaic events (clonal mosaicism for chromosome alterations and/or loss of chromosome Y) showed an increased risk of COVID-19 lethality
Impact of COVID-19 on cardiovascular testing in the United States versus the rest of the world
Objectives: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-US institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic.
Background: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality.
Methods: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States.
Results: Reductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p < 0.001). Significantly more U.S. facilities reported increased use of telehealth and patient screening measures than non-U.S. facilities, such as temperature checks, symptom screenings, and COVID-19 testing. Reductions in volumes of procedures differed between U.S. regions, with larger declines observed in the Northeast (76%) and Midwest (74%) than in the South (62%) and West (44%). Prevalence of COVID-19, staff redeployments, outpatient centers, and urban centers were associated with greater reductions in volume in U.S. facilities in a multivariable analysis.
Conclusions: We observed marked reductions in U.S. cardiovascular testing in the early phase of the pandemic and significant variability between U.S. regions. The association between reductions of volumes and COVID-19 prevalence in the United States highlighted the need for proactive efforts to maintain access to cardiovascular testing in areas most affected by outbreaks of COVID-19 infection
Canagliflozin and renal outcomes in type 2 diabetes and nephropathy
BACKGROUND Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium–glucose cotransporter 2 (SGLT2), exploratory results have suggested that such drugs may improve renal outcomes in patients with type 2 diabetes. METHODS In this double-blind, randomized trial, we assigned patients with type 2 diabetes and albuminuric chronic kidney disease to receive canagliflozin, an oral SGLT2 inhibitor, at a dose of 100 mg daily or placebo. All the patients had an estimated glomerular filtration rate (GFR) of 30 to <90 ml per minute per 1.73 m2 of body-surface area and albuminuria (ratio of albumin [mg] to creatinine [g], >300 to 5000) and were treated with renin–angiotensin system blockade. The primary outcome was a composite of end-stage kidney disease (dialysis, transplantation, or a sustained estimated GFR of <15 ml per minute per 1.73 m2), a doubling of the serum creatinine level, or death from renal or cardiovascular causes. Prespecified secondary outcomes were tested hierarchically. RESULTS The trial was stopped early after a planned interim analysis on the recommendation of the data and safety monitoring committee. At that time, 4401 patients had undergone randomization, with a median follow-up of 2.62 years. The relative risk of the primary outcome was 30% lower in the canagliflozin group than in the placebo group, with event rates of 43.2 and 61.2 per 1000 patient-years, respectively (hazard ratio, 0.70; 95% confidence interval [CI], 0.59 to 0.82; P=0.00001). The relative risk of the renal-specific composite of end-stage kidney disease, a doubling of the creatinine level, or death from renal causes was lower by 34% (hazard ratio, 0.66; 95% CI, 0.53 to 0.81; P<0.001), and the relative risk of end-stage kidney disease was lower by 32% (hazard ratio, 0.68; 95% CI, 0.54 to 0.86; P=0.002). The canagliflozin group also had a lower risk of cardiovascular death, myocardial infarction, or stroke (hazard ratio, 0.80; 95% CI, 0.67 to 0.95; P=0.01) and hospitalization for heart failure (hazard ratio, 0.61; 95% CI, 0.47 to 0.80; P<0.001). There were no significant differences in rates of amputation or fracture. CONCLUSIONS In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a median follow-up of 2.62 years
- …